QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
39.09
-0.01 (-0.03%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

QuidelOrtho Corporation provides diagnostic testing solutions.

The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units.

The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases.

The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings.

The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics.

The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use.

It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

QuidelOrtho Corporation
QuidelOrtho logo
Country United States
Founded 1979
Industry Medical Devices
Sector Healthcare
Employees 7,100
CEO Brian Blaser

Contact Details

Address:
9975 Summers Ridge Road
San Diego, California 92121
United States
Phone 858 552 1100
Website quidelortho.com

Stock Details

Ticker Symbol QDEL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001906324
CUSIP Number 219798105
ISIN Number US2197981051
Employer ID 87-4496285
SIC Code 2835

Key Executives

Name Position
Brian J. Blaser President, Chief Executive Officer and Director
Joseph M. Busky CPA Chief Financial Officer
Robert J. Bujarski J.D. Executive Vice President and Chief Operating Officer
Dr. Werner Kroll Ph.D. Executive Officer
Michael S. Iskra Executive Vice President and Chief Commercial Officer
Jonathan Siegrist Ph.D. Executive Vice President of Research and Development and Chief Technology Officer
Juliet C. Cunningham Vice President of Investor Relations
Michelle A. Hodges J.D. Senior Vice President, General Counsel and Corporate Secretary
Ronald Lee Bowman Chief Human Resources Officer
William J. Ferenczy Point of Care Business Unit Leader

Latest SEC Filings

Date Type Title
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 7, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Aug 5, 2024 144 Filing
Aug 5, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 1, 2024 10-Q Quarterly Report
Aug 1, 2024 10-K/A [Amend] Annual report
Jul 31, 2024 8-K Current Report
Jul 30, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jul 24, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Jul 15, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership